Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Fibrosis, characterized by excessive extracellular matrix accumulation, is a common feature of many connective tissue diseases, notably scleroderma (systemic sclerosis). Experimental studies suggest that a complex network of intercellular interactions involving endothelial cells, epithelial cells, fibroblasts and immune cells, using an array of molecular mediators, drives the pathogenic events that lead to fibrosis. Transforming growth factor-beta and endothelin-1, which are part of a cytokine hierarchy with connective tissue growth factor, are key mediators of fibrogenesis and are primarily responsible for the differentiation of fibroblasts toward a myofibroblast phenotype. The tight skin mouse (Tsk-1) model of cutaneous fibrosis suggests that numerous other genes may also be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been shown that persistent inflammation results in up-regulation of various proinflammatory cytokines and chemokines, which further induce the expression of growth factors (e.g., PDGF, TGF-β1, activin), stimulating fibroblast proliferation, their differentiation into myofibroblasts, and production of ECM in a variety of fibrotic diseases, including hypertrophic scars and keloids [259–261].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [259]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 1×
“These cells, which are characterized by the presence of stress fibres containing αsmooth muscle actin (SMA), play a pivotal role in ECM deposition and wound contraction during the normal wound healing process [26].”
BackgroundRegulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundThe endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515 · cited 2×
“Cardiovascular Research © Elsevier 2004 [4].”
BackgroundConnective Tissue Growth Factor: What's in a Name?
Moussad, E. E.-D. A., & Brigstock, D. R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3059 · Cited by 470 · cited 1×
“CTGF, a cytokine that stimulates fibroblast growth and upregulation of collagen and fibronectin in vitro [11], is a difficult molecule to study experimentally, but there is evidence to suggest it mediates certain effects of TGF-β and ET-1 on ECM production [12,13].”
BackgroundHocher, B., Thöne-Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V, Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H. H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 409 · cited 2×
“In this model, pronounced renal fibrosis was associated with an age-dependent decrease in glomerular filtration that culminated in fatal kidney disease [ 15 ].”
BackgroundDistler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383 · cited 1×
“For example, using this model, the protein kinase inhibitor imatinib mesylate (a selective, dual inhibitor of TGF-β and platelet-derived growth factor) was shown to have potent antifibrotic effects [22], although perhaps not in later stages of fibrosis [23].”
MethodA tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.
Siracusa, L. D., McGrath, R., Ma, Q., Moskow, J. J., Manne, J., Christner, P. J., Buchberg, A. M., & Jimenez, S. A. (1996) · Genome Research · doi:10.1101/gr.6.4.300 · Cited by 293 · cited 1×
“and the major component of microfibrils, found with or without associated elastin [17].”
BackgroundPulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Hocher, B., Schwarz, A., Fagan, K. A., Thöne-Reineke, C., El-Hag, K., Kusserow, H., Elitok, S., Bauer, C., Neumayer, H.-H., Rodman, D. M., et al. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.4030 · Cited by 219 · cited 1×
“Other work in a transgenic mouse model has shown ET-1 over-expression to lead to the recruitment of inflammatory cells in respiratory tissues and subsequent development of progressive pulmonary fibrosis [16].”
BackgroundParacrine regulation of keratinocyte proliferation and differentiation
Werner, S., & Smola, H. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01955-9 · Cited by 184 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundMechanisms and consequences of fibrosis in systemic sclerosis
Denton, C. P., Black, C. M., & Abraham, D. J. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0115 · Cited by 181 · cited 1×
“also internal organs such as lungs and kidneys, leading to organ dysfunction and failure [1].”
BackgroundSelf-citation
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
Keloids: The paradigm of skin fibrosis — Pathomechanisms and treatment
Andrews, J. P., Marttala, J., Macarak, E., Rosenbloom, J., & Uitto, J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.013 · Cited by 433
“While fibroblasts play a central role leading to ECM overproduction, epithelial-mesenchymal cross-talk has also been implicated between keratinocytes and dermal fibroblasts [24,25].”
Cell-Extracellular Matrix Interactions in Normal and Diseased Skin
Watt, F. M., & Fujiwara, H. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005124 · Cited by 384
“Fibrosis is a hallmark of many connective tissue diseases, including scleroderma and systemic sclerosis (reviewed by Ihn 2005; Krieg et al. 2007; Olson and Soriano 2009).”
BackgroundOspelt, C., Brentano, F., Rengel, Y., Stanczyk, J., Kolling, C., Tak, P. P., Gay, R. E., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24140 · Cited by 351
“Since it has been demonstrated that in pathologic conditions, skin fibroblasts appear to be more prone to produce matrix instead of matrix-degrading enzymes, it does not appear to be surprising that skin fibroblasts react differently to stimuli than do synovial fibroblasts (16,17).”
BackgroundCellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214
“The source of ECM-producing activated mesenchymal cells is controversial (3,4).”
BackgroundSelf-citationStrategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jimenez, S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 170
“functions, including increased production of fibrillar type I and type III collagens, expression of α-smooth muscle actin (α-SMA), a molecular marker of activated myofibroblasts, and reduction in the expression of genes encoding ECM–degradative enzymes (12-15).”
BackgroundActivation of TGF-β Pathway by Areca Nut Constituents: A Possible Cause of Oral Submucous Fibrosis
Khan, I., Kumar, N., Pant, I., Narra, S., & Kondaiah, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051806 · Cited by 143
“Pro-fibrogenic cytokines become key mediators of fibrosis by differentiating fibroblasts to myofibroblast phenotype in connective tissue disorders [7].”
Wermuth, P. J., & Jimenez, S. A. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0047-4 · Cited by 141
“They also support endothelial cell survival and release TGF-β that triggers transdifferentiation of fibroblasts to activated myofibroblasts [72,73], a unique population of mesenchymal cells that display increased production of fibrillar type I and type III collagens, expression of α -smooth muscle actin ( α -SMA) and…”
BackgroundKhanna, D., Saggar, R., Mayes, M. D., Abtin, F., Clements, P. J., Maranian, P., Assassi, S., Saggar, R., Singh, R. R., & Furst, D. E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30548 · Cited by 139
Remst, D. F. G., Blom, A. B., Vitters, E. L., Bank, R. A., van den Berg, W. B., Davidson, E. N. B., & van der Kraan, P. M. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38266 · Cited by 129
“Synovial fibrosis, characterized by fibroblast proliferation and an imbalance between collagen synthesis and collagen degradation, is a hallmark of osteoarthritis (OA) (1).”
BackgroundJiménez, S. A. (2013) · ISRN Rheumatology · doi:10.1155/2013/835948 · Cited by 141
Yun, S., Kim, S., & Kim, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00162 · Cited by 130
Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases
Acosta‐Herrera, M., Kerick, M., González‐Serna, D., Wijmenga, C., Franke, A., Gregersen, P. K., Padyukov, L., Worthington, J., Vyse, T. J., Alarcón-Riquelme, M. E., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214127 · Cited by 124
“Cardiovascular events and fibrosis are the most life-threatening 294 complications described in SSc, IIM, and SLE.[52-54] 295”
Invasive Intraneural Interfaces: Foreign Body Reaction Issues
Lotti, F., Ranieri, F., Vadalà, G., Zollo, L., & Di Pino, G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00497 · Cited by 112
“…share common features and mechanisms, leading to the presence of activated fibroblasts or myofibroblasts, expressing the activation marker α-SMA (smooth muscle actin) and producing ECM macromolecules, such as fibrillary type I and type III collagens (Abraham et al., 2007; Krieg et al., 2007).”
BackgroundLi, Y., Zheng, J., Liu, J., Yang, J., Liu, Y., Wang, C., Ma, X., Liu, B., Xin, G.-Z., & Liu, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00532 · Cited by 117
“In RA, fibroblast activation and extracellular matrix (ECM) remodeling are key events responsible for synovial tissue fibrosis (1, 2).”
BackgroundSaketkoo, L. A., & Espinoza, L. R. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31818d094b · Cited by 117
Noll, J. E., Williams, S. A., Tong, C. M., Wang, H., Quach, J. M., Purton, L. E., Pilkington, K., To, L. B., Evdokiou, A., Gronthos, S., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.090977 · Cited by 106
Jiménez, S. A., & Piera-Velázquez, S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.012 · Cited by 115
“The cells ultimately responsible for the severe fibrotic process affecting the lung parenchyma and for the fibroproliferative alterations in the small and middle size pulmonary arterioles in SSc are the activated myofibroblasts [13-18].”
Rao, B., Narasimhan, M., Narashiman, S., & Rajan, S. T. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7820.4231 · Cited by 112
“[4] Thomas Krieg, David Abraham, Robert Lafyatis.”
BackgroundLassance, L., Marino, G. K., Medeiros, C. S., Thangavadivel, S., & Wilson, S. E. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.02.018 · Cited by 98
“…cytokines like transforming growth factor-β (TGFβ), recruitment of bone marrow-derived cells and the development of myofibroblasts that produce disordered extracellular matrix (Guarino et al., 2009; Krieg et al., 2007; Leaf and Duffield, 2017; Maher et al., 2007; Strutz and Muller, 1999).”
InfluentialRemst, D. F. G., Davidson, E. N. B., Vitters, E. L., Blom, A. B., Stoop, R., Snabel, J. M., Bank, R. A., van den Berg, W. B., & van der Kraan, P. M. (2012) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.10.002 · Cited by 88
Guo, F., Carter, D. E., & Leask, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019756 · Cited by 85
“death, is one of the largest groups of diseases for which there is no therapy [36].”
Canady, J., Arndt, S., Karrer, S., & Bosserhoff, A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.389 · Cited by 94
“The exact accomplishment of this activation is still not clear, but recent evidence indicates that epithelial– mesenchymal cross talk has a critical role in fibrosing connective tissue disorders (Krieg et al., 2007).”
BackgroundFrontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis
Tziotzios, C., Stefanato, C. M., Fenton, D. A., Simpson, M. A., & McGrath, J. A. (2016) · Experimental Dermatology · doi:10.1111/exd.13071 · Cited by 87
Connective Tissue Growth Factor causes EMT-like cell fate changes in vivo and in vitro
Sonnylal, S., Xu, S., Jones, H., Tam, A. Y. Y., Sreeram, V. R., Ponticos, M., Norman, J. T., Agrawal, P., Abraham, D., & Crombrugghe, B. D. (2013) · Journal of Cell Science · doi:10.1242/jcs.111302 · Cited by 93
“A certain proportion of fibroblast-like cells in fibrotic lesions originate from epithelial cells that have acquired migratory and proliferative characteristics (Krieg et al., 2007).”
BackgroundSelf-citationWang, Z., Han, Z., Tao, J., Wang, J., Liu, X., Zhou, W., Xu, Z., Zhao, C., Wang, Z., Tan, R., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13157 · Cited by 87
“These cells play a crucial role in these fibrotic disorders by increasing the production of extracellular matrix (ECM), overexpressing a-smooth muscle actin and reducing the expression of genes encoding ECM-degradative enzymes [15, 16].”
BackgroundPathophysiology of systemic sclerosis: State of the art in 2014
Dumoitier, N., Lofek, S., & Mouthon, L. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.08.001 · Cited by 90
“Phenotypical changes of these fibroblasts have also been described, with the expression of alpha-smooth muscle actin (a-SMA), a marker of differentiation into myofibroblast [89].”
BackgroundRole of neurotrophins on dermal fibroblast survival and differentiation
Palazzo, E., Marconi, A., Truzzi, F., Dallaglio, K., Petrachi, T., Humbert, P. G., Schnebert, S., Perrier, É., Dumas, M., & Pincelli, C. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22811 · Cited by 79
Endothelin in Pulmonary Fibrosis
Fonseca, C., Abraham, D., & Renzoni, E. A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0388tr · Cited by 70
Self-citationWermuth, P. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · PubMed · Cited by 88
Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β
Tanaka, S., Suto, A., Ikeda, K., Sanayama, Y., Nakagomi, D., Iwamoto, T., Suzuki, K., Kambe, N., Matsue, H., Matsumura, R., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket254 · Cited by 67
Recent advances in human respiratory epithelium models for drug discovery
Yaqub, N., Wayne, G. J., Birchall, M., & Song, W. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107832 · Cited by 67
Warsinske, H., Pienaar, E., Linderman, J. J., Mattila, J. T., & Kirschner, D. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01843 · Cited by 63
Guo, F., Carter, D. E., Mukhopadhyay, A., & Leask, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027097 · Cited by 56
“Fibrosis, an often fatal condition characterized by excessive production and contraction of ECM in connective tissue, has no therapy [17,18].”
BackgroundChen, Y.-T., Wei, J.-D., Wang, J., Lee, H.-H., Chiang, E., Lai, H.-C., Chen, L., Lee, Y., Tsai, C.-C., Liu, C.-L., et al. (2011) · Spine · doi:10.1097/brs.0b013e3182053f58 · Cited by 59
Martins, V., Gonzalez De Los Santos, F., Wu, Z., Capelozzi, V., Phan, S. H., & Liu, T. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.06.005 · Cited by 52
“The origin of extracellular matrix-producing myofibroblasts is controversial.(21,37,38) They may arise from the in situ activation of quiescent resident fibroblasts in response to extracellular stimuli.”
BackgroundMeyer, M., Müller, A., Yang, J., Šulcová, J., & Werner, S. (2011) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.2011.1 · Cited by 54
“They are overexpressed in a variety of fibrotic diseases, including hypertrophic scars and keloids (Werner and Alzheimer, 2006; Krieg et al., 2007; Trojanowska, 2008).”
BackgroundHasegawa, M., Matsushita, Y., Horikawa, M., Higashi, K., Tomigahara, Y., Kaneko, H., Shirasaki, F., Fujimoto, M., Takehara, K., & Sato, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24934 · Cited by 53
Cipriani, P., Di Benedetto, P., Ruscitti, P., Liakouli, V., Berardicurti, O., Carubbi, F., Ciccia, F., Guggino, G., Zazzeroni, F., Alesse, E., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150996 · Cited by 51
Artaza, J. N., Singh, R., Ferrini, M. G., Braga, M., Tsao, J., & Gonzalez-Cadavid, N. F. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0408 · Cited by 51
Pérez‐Bocanegra, C., Solans, R., Simeón‐Aznar, C. P., Campillo, M., Fonollosa‐Pla, V., & Vilardell, M. (2010) · Rheumatology · doi:10.1093/rheumatology/keq046 · Cited by 49
Inhibition of α-SMA by the Ectodomain of FGFR2c Attenuates Lung Fibrosis
Wang, J., Zhihong, Y., Zhiyou, Z., Huang, Q., Dingding, W., Sun, L., Zhu, B., Xing, W., He, Y., & Hong, A. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00425 · Cited by 49
“Because ET-1 is an important mediator in α-SMA expression, which was induced by TGF-β through the JNK signal pathway (10,11), this result suggests that the inhibition of sFGFR2c on α-SMA expression may not be related to ET-1.”
BackgroundAu, K., Khanna, D., Clements, P. J., Furst, D. E., & Tashkin, D. P. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0016-2 · Cited by 48
“Both TGF-β and ET-1 can induce CTGF production, a cytokine that stimulates fi broblast growth and upregulates production of collagen and fi bronectin [ 8 ].”
BackgroundElastic fiber pattern in scleroderma/morphea
Walters, R. F., Pulitzer, M. P., & Kamino, H. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01201.x · Cited by 46
Desguerre, I., Arnold, L., Vignaud, A., Cuvellier, S., Yacoub‐Youssef, H., Gherardi, R. K., Chelly, J., Chrétien, F., Mounier, R., Ferry, A., et al. (2012) · Muscle & Nerve · doi:10.1002/mus.23341 · Cited by 51
Novel Role for Osteopontin in Cardiac Fibrosis
Zahradka, P. C. (2008) · Circulation Research · doi:10.1161/circresaha.107.170555 · Cited by 50
TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology
Serralheiro, P. A., Soares, A. M., Almeida, C. C., & Verde, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122534 · Cited by 52
“However, prolonged chronic stimuli lead to a long term activation of myofibroblasts (a specialized type of fibroblasts that are normally activated during wound healing) [81], which in turn may result in excessive and abnormal deposition of ECM and fibrosis (Fig re 3).”
BackgroundLncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling
Tang, R., Wang, Y.-C., Mei, X., Shi, N., Sun, C., Ran, R., Zhang, G., Li, W., Staveley-O’Carroll, K. F., Li, G., et al. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00059.2020 · Cited by 45
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
Chen, Y., Yuan, S., Cao, Y., Kong, G., Jiang, F., Li, Y., Wang, Q., Tang, M., Zhang, Q., Wang, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3206982 · Cited by 47
Ku, J. C., Raiten, J., & Li, Y. (2024) · Biomedical Engineering Advances · doi:10.1016/j.bea.2024.100118 · Cited by 49
Fava, G., DeMorrow, S., Gaudio, E., Franchitto, A., Onori, P., Carpino, G., Glaser, S. S., Francis, H., Coufal, M., Marucci, L., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01997.x · Cited by 38
“The presence of rich connective tissue into the mass could be explained by the fact that ET-1 represents a key mediator of fibrogenesis and that it is responsible for the differentiation of fibroblasts towards a myofibroblast phenotype (59).”
BackgroundKim, Y., Sundrud, M. S., Zhou, C., Edenius, M., Zocco, D., Powers, K., Zhang, M., Mazitschek, R., Rao, A., Yeo, C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913788117 · Cited by 43
Warsinske, H., Wheaton, A. K., Kim, K. K., Linderman, J. J., Moore, B. B., & Kirschner, D. E. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00183 · Cited by 38
The IL-33 gene is related to increased susceptibility to systemic sclerosis
Koca, S. S., Pehlivan, Y., Kara, M., Alıbaz-Öner, F., Öztuzcu, S., Yilmaz, N., Çetin, G. Y., Kısacık, B., Özgen, M., Pamuk, Ö. N., et al. (2016) · Rheumatology International · doi:10.1007/s00296-015-3417-8 · Cited by 37
“The infiltration of inflammatory cells such as T lymphocytes, mast cells and macrophages has been shown in the skin biopsies of patients with SSc [26, 27].”
BackgroundA review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways
Jiménez, S. A., Mendoza, F. A., & Piera-Velázquez, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551911 · Cited by 43
Clinical trials in systemic sclerosis: lessons learned and outcomes
Matucci‐Cerinic, M., Steen, V. D., Furst, D. E., & Seibold, J. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2191 · Cited by 40
“As presented in other reviews in this supplement [12,13], transforming growth factor-β appears to be an important mediator of much of the pathophysiology of SSc, particularly in terms of extracellular matrix deposition and vasculature injury.”
BackgroundJiménez, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.6222 · Cited by 35
Chitturi, P., Xu, S., Abdi, B. A., Nguyen, J., Carter, D. E., Sinha, S., Arora, R., Biernaskie, J. A., Stratton, R. J., & Leask, A. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-223859 · Cited by 39
Fujiwara, T., Kubo, T., Kanazawa, S., Shingaki, K., Taniguchi, M., Matsuzaki, S., Gurtner, G. C., Tohyama, M., & Hosokawa, K. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12059 · Cited by 31
“mentioned the importance of direct cell– cell contact between fibroblasts and keratinocytes to allow initial TGF-b activation.(33) In clinical research, keloids, in which a-SMA is often detected,(34) commonly involve symptoms of itch and pain.”
BackgroundPeripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients
Beşliu, A. N., Bănică, L. M., Predețeanu, D., Vlad, V. M., Ionescu, R., Pistol, G. C., Opriș-Belinski, D., Berghea, F., Stefănescu, M., & Matache, C. (2011) · Autoimmunity · doi:10.3109/08916934.2010.541171 · Cited by 30
Li, Y., Cheng, Z., Yu, F., Zhang, Q., Yu, S., Ding, F., & He, Q. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.859349 · Cited by 30
Treatment of rapidly progressive systemic sclerosis: current and futures perspectives
Mendoza, F. A., Mansoor, M., & Jiménez, S. A. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1114454 · Cited by 33
Proteomic Analysis of Human Dermal Fibroblast Conditioned Medium (DFCM)
Maarof, M., Lokanathan, Y., Ruszymah, H. I., Saim, A. B., & Chowdhury, S. R. (2018) · The Protein Journal · doi:10.1007/s10930-018-9800-z · Cited by 30
Myofibroblast specific targeting approaches to improve fibrosis treatment
Beaven, E., Kumar, R., Bhatt, H. N., Esquivel, S. V., & Nurunnabi, M. (2022) · Chemical Communications · doi:10.1039/d2cc04825f · Cited by 33
Interferons and scleroderma—A new clue to understanding the pathogenesis of scleroderma?
Coelho, L. F. L., de Oliveira, J. G., & Kroon, E. G. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.03.016 · Cited by 32
Cipriani, P., Benedetto, P. D., Capece, D., Zazzeroni, F., Liakouli, V., Ruscitti, P., Pantano, I., Berardicurti, O., Carubbi, F., Alesse, E., et al. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-13 · Cited by 30
“Many cytokines such as TGF-b, VEGF, CTGF, and endothelin-1 are considered as key mediators in this process, because of their skill to induce the differentiation of fibroblasts toward a myofibroblastoid phenotype [21,37].”
BackgroundKhanna, D., Seibold, J. R., Wells, A. U., Distler, O., Allanore, Y., Denton, C., & Furst, D. E. (2010) · Current Rheumatology Reviews · doi:10.2174/157339710791330768 · Cited by 34
Xu, Q., Gai, P. Y., Lv, H., Li, G. R., & Liu, X. Y. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15017228 · Cited by 27
Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases
Kinoshita, Y., Watanabe, K., Ishii, H., Kushima, H., Hamasaki, M., Fujita, M., & Nabeshima, K. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2473-3 · Cited by 27
The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis
Alnajar, A., Nordhoff, C., Schied, T., Chiquet‐Ehrismann, R., Loser, K., Vogl, T., Ludwig, S., & Wixler, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081356 · Cited by 27
“long-term inflammation occurs [1–4].”
Jang, B. S., Cheon, J. Y., Kim, S. H., & Park, W. H. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1367635 · Cited by 29
“Fibroblast cells, which are located in adventitia of native blood vessel, have important function in healing process, tissue repair and synthesizing interstitial collagens, fibronectins, and other matrix components [26].”
BackgroundDiddi, S., Bale, S., Pulivendala, G., & Godugu, C. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0527-4 · Cited by 26
Rosenbloom, J., Ren, S., & Macarak, E. J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.011 · Cited by 26
Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis
Chu, H., Wu, T., Wu, W., Tu, W., Jiang, S., Chen, S., Ma, Y., Liu, Q., Zhou, X., Li, J., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0171-3 · Cited by 23
Yin and Yang: CCN3 inhibits the pro‐fibrotic effects of CCN2
Leask, A. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0056-4 · Cited by 23
Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study
Al‐Yafeai, Z., Ananthaneni, A., Ghoweba, M., Abduljabar, H., Aziz, D. J., & Grewal, U. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15499 · Cited by 23
Richard, V. J., Solans, V., Favre, J., Henry, J., Lallemand, F., Thuillez, C., & Marié, I. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00634.x · Cited by 22
Kamath, V., Maria, S., Satelur, K. P., & Rajkumar, K. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.148729 · Cited by 22
Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Ibi, M., Kamo, M., Satoh, K., & Ishisaki, A. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2896 · Cited by 22
“The pathogenesis of fibrosis results from excess connective tissue deposition, which causes failure of various organs including scleroderma (6).”
Targeting the jagged/notch pathway: a new treatment for fibrosis?
Leask, A. (2010) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-010-0101-3 · Cited by 21
“The cell type responsible for fibrosis is a differentiated form of fibroblast, termed the myofibroblast which is highly contractile and expresses α-smooth muscle actin (α-SMA) as well as overexpressing genes encoding the extracellular matrix (Hinz et al. 2007; Krieg et al. 2007).”
BackgroundRole of endothelin in lung fibrosis
Abraham, D. (2008) · European Respiratory Review · doi:10.1183/09059180.00010907 · Cited by 20
“In fact, CCN2 is a common target for both TGF-b and ET-1 [ 20 ].”
BackgroundSelf-citationEmerging targets for the treatment of scleroderma
Leask, A. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.678833 · Cited by 20
“Isolated SSc epidermis activates dermal fibroblasts resulting inmyofibroblast differentiation via the overproduction of IL-1a, resulting in upregulation in fibroblasts of the fibrogenic cytokines TGF-b and endothelin-1 [24], which are responsible for myofibroblast differentiation [15-17].”
BackgroundMicroplasma Treatment versus Negative Pressure Therapy for Promoting Wound Healing in Diabetic Mice
Shao, P., Liao, J., Wu, S., Chen, Y.-H., & Wong, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910266 · Cited by 20
Sivakumar, P., Kitson, C., & Járai, G. (2018) · Connective Tissue Research · doi:10.1080/03008207.2018.1500557 · Cited by 20
Benedetto, P. D., Ruscitti, P., Liakouli, V., Galdo, F. D., Giacomelli, R., & Cipriani, P. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10429 · Cited by 28
“…gaining a greater understanding of the origin and differentiation pathways of myofibroblasts in vivo is a priority. in this context, recent studies (82-87) have suggested a role for mesenchymal perivascular cells (88); these cells have held various names including mural cells and pericytes, and…”
Chen, Y., Liang, C., Chen, C., Chen, J., Chang, Y., Lu, D., Chien, K., & Tai, M. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12160 · Cited by 16
“This specialized form of fibroblasts is present in abundance in fibrotic lesions, which can synthesize the extracellular matrix (Krieg et al. 2007).”
BackgroundKaieda, S., Fujimoto, K., Todoroki, K., Abe, Y., Kusukawa, J., Hoshino, T., & Ida, H. (2021) · Modern Rheumatology · doi:10.1093/mr/roab051 · Cited by 15
Muñóz, N., Pedreáñez, A. B., & Mosquera, J. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.03.010 · Cited by 20
Ranjan, P., Dutta, R. K., Colin, K., Li, J., Zhang, Q., Lal, H., Qin, G., & Verma, S. K. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.152 · Cited by 16
Yu, F., Wang, H., Liu, W., & Lu, L. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.11.029 · Cited by 14
“In humans, tissue fibrosis, a lifethreatening autoimmune disease is related to Fibulin family proteins [10].”
BackgroundEmbryonic Stem Cell–like Population in Dupuytren’s Disease
Koh, S. P., On, N., Brasch, H. D., Chibnall, A. M., Armstrong, J. R., Davis, P. F., Tan, S. T., & Itinteang, T. (2016) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001064 · Cited by 14
5Z-7-Oxozeanol Inhibits the Effects of TGFβ1 on Human Gingival Fibroblasts
Kuk, H., Hutchenreuther, J., Murphy‐Marshman, H., Carter, D., & Leask, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123689 · Cited by 16
“Excessive deposition and remodeling of connective tissue can result in fibroproliferative conditions [1], which, in adult tissues, can be characterized by the presence of scar tissue or pathological fibrosis.”
BackgroundFibroblast culture on poly(L-lactide-co-ɛ-caprolactone) an electrospun nanofiber sheet
Jang, B. S., Jung, Y., Kwon, I. K., Mun, C. H., & Kim, S. H. (2012) · Macromolecular Research · doi:10.1007/s13233-012-0180-5 · Cited by 17
Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models
Lin, L.-T., Chen, J., Lu, D., Tai, M., Liang, C., Chen, C., Pao, S., Hsu, C.-K., & Chen, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234706 · Cited by 14
Babu, P. K. V., Mirastschijski, U., Belge, G., & Radmacher, M. (2021) · European Biophysics Journal · doi:10.1007/s00249-021-01536-2 · Cited by 16
“In response to tissue injury and during wound healing, direct contact between epithelial cells and underlying fibroblasts modulates the expression levels of key enzymes such as matrix metalloproteinase-2 and -9, which are important for the wound healing process (Krieg et al. 2007).”
BackgroundTamgadge, S., & Tamgadge, A. P. (2019) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_23_19 · Cited by 12
“Defective intercellular junctions lead to fibrosis as a part of healing process has also been mentioned by Krieg et al.[6]”
BackgroundLi, A., Wu, S., Li, Q., Wang, Q., & Chen, Y. (2024) · Antioxidants · doi:10.3390/antiox13050515 · Cited by 13
“This intricate interplay of cellular and molecular processes under-scores the multifactorial nature of fibrosis and highlights the need for targeted therapeutic strategies to intervene at various stages of its progression [4–6].”
Background
Metadata
- Authors
- Krieg, T., Abraham, D., & Lafyatis, R.
- Affiliations
- University of Cologne (DE)
- The Royal Free Hospital (GB)
- Boston University (US)
- Corresponding author
- Krieg, Thomas
- Venue
- Arthritis Research & Therapy
- Published
- 2007
- Volume
- 9
- Issue
- Suppl 2
- Pages
- S4
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC2072888
- OpenAlex
- W2145999911
- Cited by
- 151
- References
- 35
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 11 · 2017: 10 · 2016: 13 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 12
- Type
- conference abstract
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Arthritis Research & Therapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- OpenBU (Boston University) (submittedVersion)
- Funders
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibrosis, connective tissue diseases, systemic sclerosis, myofibroblasts, extracellular matrix accumulation, TGF-beta, endothelin-1, connective tissue growth factor, fibroblast differentiation, tight-skin mouse, skin fibrosis, endothelial cells, immune cells
- MeSH terms
- Animals, Cell Communication, Connective Tissue Diseases, Epithelial Cells, Fibroblasts, Fibrosis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.